Bionovate Technologies Corp 最大收入來源為 First Rail,在最近的收益報告中收入為 4,013,100,000。就地區而言,United Kingdom / Republic of Ireland 是 Bionovate Technologies Corp 的主要市場,收入為 5,066,300,000。
Bionovate Technologies Corp 是否盈利?
無,根據最新的財務報表,Bionovate Technologies Corp 的淨損失為 $0
Bionovate Technologies Corp 有負債嗎?
無,Bionovate Technologies Corp 的負債為 0
Bionovate Technologies Corp 的流通股有多少?
Bionovate Technologies Corp 的總流通股為 0
關鍵數據
前收市價
$0.0001
開盤價
$0.0001
當日範圍
$0.0001 - $0.0001
52週區間
-
交易量
100
平均成交量
--
股息收益率
--
每股盈餘 (TTM)
--
市值
--
什麼是 BIIO?
Bionovate Technologies Corp. engages in the investments and marketing of patents, and licenses which bring healthcare and lifestyle diagnostics through mobile devices. The company is headquartered in Cham, Zug and currently employs 0 full-time employees. The company went IPO on 2014-03-28. The firm is involved in the review of opportunities for merger and acquisition. The firm has no operations.